Enveric Biosciences Stock Price on October 10, 2024
| ENVB Stock | USD 0.33 0.01 2.94% |
Below is the normalized historical share price chart for Enveric Biosciences extending back to August 22, 1995. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Enveric Biosciences stands at 0.33, as last reported on the 25th of November, with the highest price reaching 0.36 and the lowest price hitting 0.33 during the day.
If you're considering investing in Enveric Stock, it is important to understand the factors that can impact its price. Enveric Biosciences secures Sharpe Ratio (or Efficiency) of -0.13, which denotes the company had a -0.13% return per unit of risk over the last 3 months. Enveric Biosciences exposes twenty-four different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Enveric Biosciences' Variance of 22.02, mean deviation of 3.22, and Standard Deviation of 4.69 to check the risk estimate we provide.
At present, Enveric Biosciences' Common Stock Shares Outstanding is projected to increase significantly based on the last few years of reporting. The current year's Other Stockholder Equity is expected to grow to about 103.9 M, whereas Total Stockholder Equity is forecasted to decline to about 1.9 M. . As of November 25, 2024, Price To Sales Ratio is expected to decline to 0.33. In addition to that, Price Earnings Ratio is expected to decline to -170.44. Enveric Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 24th of June 2015 | 200 Day MA 0.6997 | 50 Day MA 0.4547 | Beta 0.469 |
Enveric |
Sharpe Ratio = -0.1265
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | ENVB |
Estimated Market Risk
| 4.75 actual daily | 42 58% of assets are more volatile |
Expected Return
| -0.6 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.13 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Enveric Biosciences is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Enveric Biosciences by adding Enveric Biosciences to a well-diversified portfolio.
Price Book 0.8389 | Enterprise Value Ebitda 0.2891 | Price Sales 0.0831 | Shares Float 8.6 M | Wall Street Target Price 8.32 |
Related Headline
Elevation Oncology Headline on 10th of October 2024
What Makes Elevation Oncology a New Strong Buy Stock by finance.yahoo.com
Elevation Oncology might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank 1 .
Enveric Biosciences Valuation on October 10, 2024
It is possible to determine the worth of Enveric Biosciences on a given historical date. On October 10, 2024 Enveric was worth 0.43 at the beginning of the trading date compared to the closed value of 0.44. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Enveric Biosciences stock. Still, in general, we apply an absolute valuation method to find Enveric Biosciences' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Enveric Biosciences where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Enveric Biosciences' related companies.
| Open | High | Low | Close | Volume | |
| 0.42 | 0.42 | 0.41 | 0.42 | 32,600 | |
10/10/2024 | 0.43 | 0.44 | 0.41 | 0.44 | 52,100 |
| 0.44 | 0.45 | 0.41 | 0.42 | 71,281 |
| Backtest Enveric Biosciences | | | Enveric Biosciences History | | | Enveric Biosciences Valuation | Previous | Next |
Enveric Biosciences Trading Date Momentum on October 10, 2024
| On October 11 2024 Enveric Biosciences was traded for 0.42 at the closing time. The top price for the day was 0.45 and the lowest listed price was 0.41 . The trading volume for the day was 71.3 K. The trading history from October 11, 2024 was a factor to the next trading day price decrease. The overall trading delta against the next closing price was 4.55% . The overall trading delta against the current closing price is 6.82% . |
Enveric Biosciences Fundamentals Correlations and Trends
By evaluating Enveric Biosciences' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Enveric Biosciences' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Enveric financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Enveric Biosciences Stock history
Enveric Biosciences investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Enveric is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Enveric Biosciences will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Enveric Biosciences stock prices may prove useful in developing a viable investing in Enveric Biosciences
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 2.2 M | 2.3 M | |
| Net Loss | -44.1 M | -41.9 M |
Enveric Biosciences Stock Technical Analysis
Enveric Biosciences technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Enveric Biosciences Period Price Range
Low | November 25, 2024
| High |
0.00 | 0.00 |
Enveric Biosciences cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Enveric Biosciences November 25, 2024 Market Strength
Market strength indicators help investors to evaluate how Enveric Biosciences stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Enveric Biosciences shares will generate the highest return on investment. By undertsting and applying Enveric Biosciences stock market strength indicators, traders can identify Enveric Biosciences entry and exit signals to maximize returns
Enveric Biosciences Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Enveric Biosciences' price direction in advance. Along with the technical and fundamental analysis of Enveric Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Enveric to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | (0.09) | |||
| Jensen Alpha | (0.65) | |||
| Total Risk Alpha | (1.36) | |||
| Treynor Ratio | (2.30) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Complementary Tools for Enveric Stock analysis
When running Enveric Biosciences' price analysis, check to measure Enveric Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Enveric Biosciences is operating at the current time. Most of Enveric Biosciences' value examination focuses on studying past and present price action to predict the probability of Enveric Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Enveric Biosciences' price. Additionally, you may evaluate how the addition of Enveric Biosciences to your portfolios can decrease your overall portfolio volatility.
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Stocks Directory Find actively traded stocks across global markets | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data |